Check out eyeforpharma's comprehensive coverage of pharma's emerging markets. For exclusive business insight into key strategies to succeed in Brazil, Russia, India, China, and Mexico, download eyeforpharma's Pharma Emerging Markets Report 2011-12.
Emerging markets strategies
Leveraging launch experience in pharma's emerging markets
Strategic approaches to emerging markets
Pfizers eCard and adherence in emerging markets
How to get ahead in 'pharmerging' markets
Strategies for Emerging Markets sales success
Forecasting for emerging markets
Specific emerging markets
Brazil - Breaking into the Brazilian pharma market
China - Cracking the Chinese pharma market
Egypt - RX for pharma in the new Egypt
India - Getting into the Indian pharma market
India & China - Get ready for an Asian Game Changer
Mexico - Making the most of the Mexican pharma market
Middle East - The Middle East: A pharma market in the making
Middle East - Forecasting the Middle East: An uncertain enviroment for pharma
Russia - Reassessing Russia's pharma market
South Korea - Strategies for growth in South Korea's pharma market
Turkey - Transforming the Turkish pharma market
HTAs and market access
Market access: How to meet both marketing authorisation and HTA needs
HTAs go global: What it means for market access
Health data and comparative effectiveness research
How to build value through comparative effectiveness research
Ben Steele talks with Eduardo Tchouhadjian, CEO of E. Tchouhadjian & Associates, about how...
NICE have announced the publication a new set of briefings designed to increase uptake of...
30% of pharma executives expect business as usual, as they admit to expecting blockbuster-type...
